ST. LOUIS, Mo – With the recent problem of drug resistant bacteria on the rise, the Centers for Disease Control and Prevention has announced funding to selected medical centers to study the phenomenon.

The problem has recently come into focus after the first case of bacteria resistance to Colistin, a so-called last-resort antibiotic, that occurred in April, 2016 to a U.S. resident.

One of five medical centers in the country scheduled to receive CDC funding is Washington University in St. Louis.

An estimated 23,000 people die in the U.S. yearly, as a result of bacterial infections that cannot be successfully treated with antibiotics.